TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
AKBA

Akebia Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.919$ -1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Akebia Therapeutics, Inc. (AKBA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 377 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AKBA
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.2 35 111 143 300 364 997 771 644 529 356 242 221 377
2.2 33 110 141 296 358 468 310 371 271 185 118 114 185
1.6 21 33 50 187 70 105 148 229 150 90 43 52 185
1.6 33 109 138 260 318 322 148 269 150 90 43 52 185
0.1 0.1 0.0 – 34 34 17 39 29 52 40 39 34 47
– – 0.0 0.0 0.0 0.0 114 116 61 37 22 16 16 16
– 0.0 0.2 0.5 2.6 3.6 8.0 10 8.6 6.8 5.2 – – –
– – 0.0 0.0 0.0 0.0 55 55 55 59 59 59 59 59
– – 0.0 0.0 0.0 0.0 328 291 144 108 72 36 – –
4.9 3.9 6.9 12 232 245 361 376 397 455 351 272 270 344
4.9 3.9 6.9 12 114 144 266 208 187 261 130 100 81 163
– 0.0 – 0.0 0.0 1.0 15 5.0 5.3 102 37 24 9.7 40
0.4 0.7 2.0 2.3 2.0 7.0 43 39 41 34 18 15 15 21
– 0.0 0.0 0.0 0.0 0.0 – 77 99 1.8 34 17 39 48
-2.7 31 104 131 68 119 636 395 248 74 5.2 -31 -49 33
-60 -64 -101 -161 -297 -374 -514 -794 -1,178 -1,463 -1,557 -1,609 -1,678 -1,684
10 15 15 26 38 44 117 118 138 166 183 187 211 257

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?